This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Table of Contents Sr# Headings 1 Introduction: The Power of Marketing Networks 2 What Are Marketing Networks? Without strong roots (your networks), the branches (your strategies) cant grow. In the pharmaceutical industry , harnessing marketing networks is essential to driving successful campaigns.
The Pharma Marketing Network serves as an ideal destination for this kind of weekend deep-dive. By devoting even an hour to the Pharma Marketing Network, you can absorb deep-dive content without multitasking. From navigating HCP engagement strategies to optimizing branded content under FDA oversight, the articles are far from generic.
Regulators have become increasingly concerned about the potential for medical devices to become a vector for spreading malware attacks across hospital networks, resulting in untold patient harm and billions of dollars globally.
Imagine a time when pharmaceutical ads simply told patients what to ask their doctor. Today, patient marketing is no longer a one-way street. This article dives deep into how patient marketing has changed, whats driving this transformation, and what strategies are leading the way for 2025 and beyond.
This guide breaks down best practices for PPC campaign optimization , helping pharma marketers reach HCPs and patients without wasting ad spend. Pay-per-click (PPC) advertising allows brands to reach healthcare professionals (HCPs) and patients when they are actively searching for treatment options, drug information, or medical education.
It must convert visitors into leads , provide clear and accurate medical information , and ensure compliance with FDA, HIPAA, and ad platform policies. Whether targeting healthcare professionals (HCPs), patients, or caregivers , a poorly optimized page can result in high bounce rates, low conversions, and missed opportunities.
took a step towards its vision of transforming chronic care management with Polso , the company’s Remote Patient Monitoring (RPM) solution, achieving 510(k) clearance from the U.S. Food and Drug Administration (FDA). “FDA clearance is an important validation of our technology. ChroniSense Medical Ltd.
Medical device and technology company Lazurite has received recognition from Medical Device Network Excellence Awards & Rankings, one of the largest, most prestigious, and widely recognized programs in the industry. All Commended companies will be entered into the Medical Device Network Awards at the end of the year. “The
Thats why referral marketing is gaining traction among pharmaceutical brands looking to increase engagement with both healthcare professionals and patients. Similarly, when patients share their experiences with others, it can drive interest more effectively than brand messaging alone. In pharma, however, the dynamic is more nuanced.
Introduction The pharmaceutical industry faces unique challenges in digital marketing, especially when it comes to reaching healthcare professionals (HCPs) and patients effectively. In pharma marketing, ad retargeting plays a crucial role in educating patients and HCPs about new treatments, clinical trials, and brand offerings.
Which platforms provide valuable insights for reaching healthcare professionals (HCPs) and patients? Digital platforms provide a way to streamline outreach efforts, measure campaign performance, and engage with both healthcare professionals and patients.
In a highly regulated industry, choosing the right keywords can determine whether your ads reach healthcare professionals, patients, or caregivers effectively. Understanding how patients and healthcare professionals search for medical information is key. Using FDA-approved terminology prevents ad disapprovals and regulatory scrutiny.
Social media advertising now plays a crucial role in reaching healthcare professionals (HCPs) and patients , allowing pharma brands to engage, educate, and build trust like never before. The way HCPs, patients, and caregivers seek information has changed. For expert pharma marketing insights, visit Pharma Marketing Network.
Develop a Deep Understanding of Your Products Knowing how a drug works, its mechanism of action, indications, contraindications, and patient impact will make your marketing strategies more credible. Organizations like the FDA (U.S.), Understand Regulatory Compliance Pharma marketing is heavily regulated.
With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. Strict ad copy guidelines , including FDA-mandated fair balance requirements. Geo-target medical conferences and hospital networks.
Food and Drug Administration (FDA) 510(k) clearance and launch of a next-generation RhinAer® stylus. The new RhinAer is designed to provide physicians with improved visualization, easier access and tissue apposition, especially in patients with narrow nasal airways. Aerin Medical Inc.,
The increasing integration of platforms like LinkedIn, X (formerly Twitter), YouTube, and even TikTok has dramatically shifted how pharma brands engage with healthcare professionals (HCPs), patients, and caregivers. Brands can host live Q&As, respond to comments, and share patient stories in authentic ways that create community and trust.
New FDA guidelines, competitor brand moves, and media spending trends all influence how your brand should show up in-market. Moreover, understanding the latest developments in AI, digital health, and patient engagement can position your team to adapt early. Start by bookmarking reliable, industry-recognized sources.
They must be highly targeted, compliant with FDA and HIPAA guidelines, and designed to generate meaningful interactions rather than just impressions. When executed correctly, they can drive brand awareness, increase HCP engagement, and support patient education initiatives. patient education clips or expert interviews).
Traditional outreach methods are no longer enough to engage healthcare professionals (HCPs) and patients in a digital-first world. So how can pharma brands maximize their return on investment (ROI) while ensuring compliance with FDA and HIPAA regulations ? Reaching Healthcare Professionals (HCPs) HCPs dont search the way patients do.
Artificial intelligence is revolutionizing how pharma brands engage with healthcare professionals (HCPs) and patients, optimizing advertising campaigns, and improving customer experiences. Those that embrace AI-driven marketing solutions will see higher engagement, better ROI, and improved patient outcomes.
Potrero Medical announced that the FDA granted Breakthrough Device Designation for their AKI Predict machine learning algorithm, for the advanced prediction of acute kidney injury (AKI) associated with intra-abdominal hypertension (IAH) in cardiac post-surgical intensive care patients. About Potrero Medical. Potrero Medical, Inc.
In this article, well dive into key pharma digital marketing strategies that can help pharma brands connect with healthcare professionals (HCPs), patients, and stakeholders effectively. Improve patient engagement with valuable content and resources. Without the right strategy, you risk getting lost in a sea of content.
Marketing in pharma has undergone a radical shift, propelled by digital transformation, patient-centric demands, and evolving regulatory landscapes. Pharmaceutical brands like Dupixent, Keytruda, and Ozempic are leading the way with creative digital campaigns that blend patient education with dynamic storytelling.
Food and Drug Administration (FDA) 510(k) clearance for its CellFX System, expanding the indication for use to include the treatment of sebaceous hyperplasia in patients with Fitzpatrick skin types I-III. See Full Press Release at the Source: Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia.
This most recent FDA 510(k) clearance extends the system’s previous FDA clearances and permits the activation of software functionality that connects to the patient’s bedside monitor and openly transmits treatment information to the central nursing station. ” About IRRAS.
The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled.
Food and Drug Administration (FDA) has cleared its Tasso+ lancet as a Class II medical device. Healthcare systems and physicians will also be able to use the Tasso+ device with compatible collection tubes to make determinations on blood chemistries for their patients and expand care access. Tasso, Inc., About Tasso.
Food & Drug Administration (FDA) for its smaller-diameter CurvaFix® IM Implant indicated for fixation of fractures of the pelvis. The new 7.5mm device is designed to simplify surgery and to provide strong, stable, curved fixation in smaller patients. CurvaFix, Inc., every year. About CurvaFix, Inc. CurvaFix, Inc.
Food and Drug Administration (FDA) granted Breakthrough Device Designation for the Company’s EndoStim System. “We are pleased that the FDA has recognized the therapeutic potential of the EndoStim System as a new treatment in development for drug refractory GERD,” said Eric Goorno, Chief Executive Officer of EndoStim. .
Introduction Social media advertising has become an essential part of pharmaceutical marketing, offering direct access to healthcare professionals (HCPs), patients, and caregivers. Facebook and Instagram for Patient Awareness These platforms are well-suited for patient engagement and disease awareness campaigns.
Lydus Medical is pleased to announce that the Vesseal has received FDA clearance 510(k). The Vesseal is designed to mimic the skill set and dexterity needed to deliver quality patient care in microsurgical anastomoses. Lydus Medical. Press Release by: Lydus Medical. Are you hiring?
On November 17, 2022, the FDA approved Provention Bio’s Tzield (teplizumab) , making it the first and only treatment to delay the onset of type 1 diabetes (T1D). The international T1D network TrialNet’s research was instrumental in the FDA’s approval of the first drug to delay T1D in at-risk people.
For instance, while patients prioritize benefits and side effects, healthcare providers look for clinical evidence and efficacy. A campaign that shares a real patient success story can evoke trust and engagement. FDA Guidelines for DTC Ads: The FDA requires ads to present both benefits and risks equally.
an innovative surgical technology company dedicated to providing less invasive options for pediatric patients, announced U.S. FDA clearance for expanded indications for use for the Hummingbird® Tympanostomy Tube System (TTS) for office-based pediatric ear tube procedures. This device has been a gamechanger for patients and families.
The newly approved Axonics R20 neurostimulator is labeled for a functional life in the body of at least 20 years and reduces how frequently a patient needs to recharge their implanted device to just once every 6 to 10 months for only one hour. This compares to the third-generation’s recharge interval of once a month for one hour.
HemoSonics, LLC , a leading medical device company delivering individualized diagnostic solutions for Patient Blood Management (PBM), announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the Quantra Hemostasis System with QStat Cartridge. market today.
Food and Drug Administration (FDA) 510(k) clearance of the BiWaze ® Clear System. This new airway clearance system helps patients clear their airways as well as prevent or treat atelectasis by using Oscillating Lung Expansion (OLE) therapy. We are proud to introduce this innovative OLE therapy system.” Are you hiring?
As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcare providers. With advancements in technology, increasing competition, and changing patient expectations, pharma marketers need to stay ahead of the curve. Patient-Centric Marketing Patients want to feel heard.
These insights help pharma marketers understand how content performs, what resonates with healthcare professionals (HCPs) and patients, and where adjustments are needed. For pharmaceutical companies, this can provide insights into public perception of drug launches, patient experiences, and industry discussions.
Food and Drug Administration (FDA) for 510(k) clearance. If FDA clearance is obtained, the ALICE device production line will be extended for Low-Rate Initial Production (LWRIP), which is an important operational stage in developing infrastructure to support serial manufacturing, quality control and shipping.
Are you targeting healthcare providers (HCPs), patients, or payers? Craft a Patient-Centric Approach Todays consumers want more than medication; they want solutions. For instance, campaigns for branded drugs like Lipitor and Jardiance have gained traction by focusing on patients real-life experiences.
Food and Drug Administration (FDA) has granted the first marketing clearance for its SCINTIX biology-guided radiotherapy, a cutting-edge treatment applicable for early and late-stage cancers. This expands the RefleXion ® X1 into the only dual-treatment modality platform that can treat patients with indicated solid tumors of any stage.
a commercial-stage healthcare business dedicated to neonatal intensive care and the acute care hospital community, announced FDA approval of the newest generation of its tankless inhaled nitric oxide (iNO) delivery system. . I can care for my patients through the operation of just one console,” she added. VERO Biotech Inc.,
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content